A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

~5 mi. (Pompano Beach, Florida, +23 more cities)

Clinical Research Center of Florida

Non-Muscle Invasive Bladder Carcinoma

BCG solution, +1 more drug

immunotherapy

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

~5 mi. (Pompano Beach, Florida, +31 more cities)

Clinical Research Center of Florida

Non-Muscle Invasive Bladder Carcinoma

BCG solution, +1 more drug

immunotherapy

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

~6 mi. (Fort Lauderdale, Florida, +523 more cities)

Holy Cross Hospital

Clear Cell Renal Cell Carcinoma

cabozantinib, +2 more drugs

immunotherapy, +1 more type

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~6 mi. (Fort Lauderdale, Florida, +744 more cities)

Holy Cross Hospital

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

~6 mi. (Fort Lauderdale, Florida, +244 more cities)

Holy Cross Hospital

Bladder Urothelial Carcinoma, +4 more conditions

atezolizumab, +4 more drugs

immunotherapy

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

~6 mi. (Fort Lauderdale, Florida, +127 more cities)

Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center

BRAF V600E

Colorectal Carcinoma

cetuximab, +3 more drugs

chemotherapy, +1 more type

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~6 mi. (Fort Lauderdale, Florida, +664 more cities)

Holy Cross Hospital

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~6 mi. (Fort Lauderdale, Florida, +825 more cities)

Holy Cross Hospital

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

~6 mi. (Fort Lauderdale, Florida, +172 more cities)

Holy Cross Hospital

Urothelial Carcinoma

cisplatin, +3 more drugs

chemotherapy, +1 more type

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

~6 mi. (Fort Lauderdale, Florida, +327 more cities)

Holy Cross Hospital

Multiple Myeloma

bortezomib, +3 more drugs

chemotherapy, +3 more types

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

~6 mi. (Fort Lauderdale, Florida, +656 more cities)

Broward Health Medical Center

Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers

Colon Adenocarcinoma, +1 more condition

atezolizumab, +3 more drugs

chemotherapy, +1 more type

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

~6 mi. (Fort Lauderdale, Florida, +606 more cities)

Holy Cross Hospital

CD274 Amplification

Angiosarcoma, +26 more conditions

ipilimumab, +1 more drug

immunotherapy